Sandu Pharmaceuticals Ltd.

Financial

	Sandu Pharmaceutical	JFL Life Sciences	Shelter Pharma
Operational Metrics
Financials
5 yr Average ROE	3.94 %	11.5 %	15.08 %
5yr average Equity Multiplier	1.34	3.23	1.38
5yr Average Asset Turnover Ratio	1.27	0.95	2.02
5yr Avg Net Profit Margin	2.31 %	4.98 %	7.29 %
Price to Book	1.14	1.19	0.0
P/E	30.68	11.23	7.03
5yr Avg Cash Conversion Cycle	27.73 Days	217.93 Days	151.86 Days
Inventory Days	71.51 Days	85.64 Days	65.6 Days
Days Receivable	26.2 Days	186.74 Days	77.72 Days
Days Payable	79.23 Days	98.82 Days	5.04 Days
5yr Average Interest Coverage Ratio	28.27	3.02	71.95
5yr Avg ROCE	5.77 %	18.94 %	21.3 %
5yr Avg Operating Profit Margin	3.87 %	9.53 %	11.0 %
5 yr average Debt to Equity	0.0	1.19	0.04
5yr CAGR Net Profit	-1.69 %	55.85 %	138.7 %
5yr Average Return on Assets	2.94 %	4.15 %	11.22 %
Shareholdings
Promoter Holding	42.9 %	67.47 %	52.32 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-7.53 %	0.0	-4.57 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Sandu Pharmaceutical	JFL Life Sciences	Shelter Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical Products 0 Others 100	Product Wise Break-Up Pharmaceuticals 100.0	Product Wise Break-Up Pharmaceutical Products 0 Others 100